Retractable Technologies, Inc.Retractable Technologies, Inc.Retractable Technologies, Inc.
  • Solutions
    • Insulin
      • VanishPoint Insulin Syringe
    • Immunization
      • VanishPoint Syringe
      • EasyPoint Needle
    • Blood Collection
      • EasyPoint Blood Collection Tube with Needle
      • VanishPoint Blood Collection Set
    • Allergy
      • VanishPoint Syringe
    • General Purpose
      • VanishPoint Syringe
      • EasyPoint Needle
    • Infusion
      • VanishPoint IV Catheter
  • Products
    • VanishPoint Syringe
    • VanishPoint Insulin Syringes
    • EasyPoint Needle
    • EasyPoint Blood Collection Tube with Needle
    • VanishPoint Blood Collection Set
    • VanishPoint IV Catheter
  • About
    • Careers
    • Investor Relations
  • Media
    • Blog
    • Latest Nurse Point Magazine Issue
    • Press Releases
  • Resources
  • Contact
    • Sales Directory
  • Social Media
  • Social Media
  • Social Media
  • Press-Releases-Featured-ImageRetractable Technologies, Inc. Results for the Periods Ended September 30, 2024Press Releases
    November 14, 2024 November 14, 2024Retractable Technologies, Inc. Results for the Periods Ended September 30, 2024
    LITTLE ELM, Texas - Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $10.3 million for the third quarter of 2024 and an operating loss of $5.1 million for the period, as compared to total net sales for the same period last year...
    34 Likes
  • Press-Releases-Featured-ImageRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersPress Releases
    September 30, 2024 October 14, 2024Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
    LITTLE ELM, Texas - Retractable Technologies, Inc. ("Retractable") (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively....
    14 Likes
  • Press-Releases-Featured-ImageRetractable Technologies, Inc. Files Complaint in United States Court of International TradePress Releases
    September 30, 2024 October 14, 2024Retractable Technologies, Inc. Files Complaint in United States Court of International Trade
    LITTLE ELM, Texas - Retractable Technologies, Inc. (NYSE American: RVP) announces that on September 26, 2024, it filed a complaint in the United States Court of International Trade against defendants involved in the issuance of a recent decision implementing a 100% tariff on syringes and...
    16 Likes
  • Press-Releases-Featured-ImageTariffs Finalized on Chinese ImportsPress Releases
    September 20, 2024 October 14, 2024Tariffs Finalized on Chinese Imports
    LITTLE ELM, Texas - Retractable Technologies, Inc. (NYSE American: RVP) announces that on September 13, 2024, the Office of the United States Trade Representative ("USTR") revealed final adjustments to tariffs placed on Chinese imported syringes and needles. Despite initially proposing a 50% rate, the USTR...
    12 Likes
  • Press-Releases-Featured-ImageRetractable Technologies, Inc. Results for the Periods Ended June 30, 2024Press Releases
    August 15, 2024 August 15, 2024Retractable Technologies, Inc. Results for the Periods Ended June 30, 2024
    LITTLE ELM, Texas - Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $6.0 million for the second quarter of 2024 and an operating loss of $5.8 million for the period, as compared to total net sales for the same period last year...
    15 Likes
  • Press-Releases-Featured-ImageRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersPress Releases
    June 28, 2024 June 28, 2024Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
    LITTLE ELM, Texas - Retractable Technologies, Inc. ("Retractable") (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively....
    14 Likes
  • Press-Releases-Featured-ImageRetractable Technologies, Inc. Results for the Period Ended March 31, 2024Press Releases
    May 15, 2024 May 15, 2024Retractable Technologies, Inc. Results for the Period Ended March 31, 2024
    LITTLE ELM, Texas - Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $7.6 million for the first three months of 2024 and an operating loss of nearly $3.0 million for the period, as compared to total net sales for the same period...
    14 Likes
  • Press-Releases-Featured-ImageRetractable Technologies, Inc. Reports Results for 2023Press Releases
    March 29, 2024 March 29, 2024Retractable Technologies, Inc. Reports Results for 2023
    LITTLE ELM, Texas - Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2023. Further details concerning the results of operations as well as other matters are available in Retractable's Form 10-K filed on March 29, 2024...
    17 Likes
  • Press-Releases-Featured-ImageRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersPress Releases
    March 29, 2024 March 29, 2024Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
    LITTLE ELM, Texas - Retractable Technologies, Inc. ("Retractable") (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively....
    18 Likes
  • Press-Releases-Featured-ImageSafety Communication from FDA Is Not Related to Vanishpoint® SyringePress Releases
    December 18, 2023 December 18, 2023Safety Communication from FDA Is Not Related to Vanishpoint® Syringe
    You may have heard about the November 30, 2023 FDA Safety Communication, “Evaluating Plastic Syringes Made in China for Potential Device Failures.” Retractable Technologies Inc. wants to assure you that the safety communication does not refer or relate to VanishPoint safety syringes from Retractable Technologies....
    14 Likes
  • Prev
  • 01
  • 02
  • 03
  • 04
  • …
  • 21
  • 22
  • Next

Categories

  • In the News
  • Nurse Point Magazine
  • Press Releases
  • RTI History

Recent Posts

  • Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
  • Retractable Technologies Welcomes Congressional Leaders to Highlight Texas Innovation and U.S. Supply Chain Readiness
  • Retractable Technologies, Inc. Results for the Periods Ended June 30, 2025
  • Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
  • Retractable Technologies, Inc. Results for the Period Ended March 31, 2025
COMPANY
  • Careers
  • Press Releases
  • Patents
  • Privacy
Technologies
  • VanishPoint Syringes
  • VanishPoint Insulin Syringes
  • EasyPoint Needles
  • PerfectPoint Technology
QUICK LINKS
  • Sales Directory
  • Nurse Point Magazine
  • Investors
  • About RTI

GET IN TOUCH

511 Lobo Ln
Little Elm, TX 75068
  • (972) 294-1010
  • rtiservice@retractable.com
Retractable Technologies, Inc.
© 2025 Retractable Technologies, Inc. All rights reserved. Retractable Technologies, VanishPoint, EasyPoint, Real Safety, PerfectPoint, and their associated logos are trademarks of Retractable Technologies, Inc.